RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one chemotherapy drug may kill more tumor cells. PURPOSE: Ph

NIAID Data Ecosystem80

Study of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation

KRAS突变治疗

实体瘤临床试验

This is a Phase 1/2, open-label, multicenter, study evaluating the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1133 in patients with advanced solid tumor malignancy harboring a KRAS G

NIAID Data Ecosystem60

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

PD-L1抑制剂治疗持续时间

实体瘤临床试验

Based on the overwhelming positive response to this survey and the large number of patients being treated with PD-1/PD-L1 therapy in the UPMC system, the investigators are proposing a trial that will

NIAID Data Ecosystem60

Dataset from A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation KRYSTAL-1

资源简介：

Dataset from A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation KRYSTAL-1

资源简介：

相关数据集